RadioMedix
Houston
About RadioMedix
RadioMedix is a privately held biotechnology company focused on innovative new targeted radiopharmaceuticals for diagnosis and therapy of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2022)
- Website: radiomedix.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/radiomedix-24537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.